Company intelligence / Profile preview

XEn Plus

Megrine, Ben Arous, Tunisiaxenlabo.com ↗

Ownership: Private
Development stage: Other

Overview

XEn Plus (also known as Laboratoire XEN) is a Tunisian pharmaceutical and nutraceutical company founded in 2016 and headquartered in Megrine, Ben Arous. The company specializes in the development, manufacturing, and commercialization of dietary supplements, dermo-cosmetics, and therapeutic health products. Its diverse portfolio includes products for sleep enhancement (Dorzen), women's health and fertility (InoPK, Fertillo), and essential mineral/vitamin supplementation (Kela Fer, Kela Zinc, Kela Mag, Trio B). XEn Plus collaborates with international partners, such as Sederma France, to formulate and clinically validate its dermo-cosmetic and therapeutic offerings.

Therapeutic areas: PsychiatryWomen's HealthInfectious DiseasesEndocrinologyHematologyMetabolic Disorders
Modalities: Small moleculeDietary supplement
Industry: Pharma

Partnerships

Sederma France

Beyond the preview

Go deeper on XEn Plus.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on XEn Plus.